Liver cancer is a common clinical malignant tumor, which seriously threatens human health due to its hidden onset, difficult treatment, and poor prognosis. To achieve the "Healthy China 2030" goal, it is particularly important to prevent the occurrence of cancer. Liver precancerous lesions are an important period that needs to be experienced in the evolution of liver cancer, and preventing the formation of precancerous lesions is a key step in the prevention and treatment of liver cancer. Different from Western medicine for the treatment of causes and the characteristics of large side effects of Western medicine, Chinese medicine pays attention to the holistic concept and treatment based on syndrome differentiation, and strives to prevent diseases before they occur, and prevent changes from existing diseases, so it has unique advantages in the treatment of difficult diseases. In recent years, the prevention and treatment of liver precancerous lesions by traditional Chinese medicine has attracted more and more attention. In this paper, by reviewing relevant literature, combing the etiology and pathogenesis of liver precancerous lesions, the application and research of single flavor Chinese medicine, traditional Chinese medicine compound, acupuncture and moxibustion in the prevention and treatment of liver precancerous lesions are summarized as follows.

Yang Tianwen, Liao Yu, Lyu Wenliang. Research on the Application of Traditional Chinese Medicine in the Prevention and Treatment of Liver Precancerous Lesions. Frontiers in Medical Science Research (2023) Vol. 5, Issue 9: 24-31. https://doi.org/10.25236/FMSR.2023.050905.

[1] Liver Cancer Committee, Chinese Anti-Cancer Association. Chinese Guidelines for integrated Diagnosis and Treatment of cancer - Simplified version of liver cancer [J]. Chinese Oncology Clinic, 2022, 49(17):865-873. 

[2] Liu Z, Xu K, Chen X, et al. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study[J]. Int J Epidemiol, 2021, 50(1):128-142

[3] Di Tommaso L, Sangiovanni A, Roncalli M, et al. Advanced precancerous lesions in the liver[J]. Best Pract Res Clin Gastroenterol, 2013, 27(2):269-284

[4] Ning Lin, Sun Jianguang. Research progress of Traditional Chinese and Western medicine in primary liver cancer precancerous lesions[J]. World Science and Technology Modernization of Traditional Chinese Medicine, 2019, 23(10):3590-3598. 

[5] Yan S Y, Fan J G. Advances in the study of non-infectious liver diseases and precancerous lesions of hepatocellular carcinoma[J]. Chin J Hepatol, 2019, 27(7):487-490

[6] Chinese Preventive Medical Association Hepatobiliary Disease Prevention and Control Committee. Guidelines for stratified screening and monitoring of primary liver cancer [J]. Journal of Hepatobiliary Diseases, 2021, 37(2):286-295. 

[7] Xia Feng, Li Xuesong. Multi-disciplinary expert consensus edition of diagnosis and treatment of precancerous lesions in hepatocellular carcinoma [J]. Journal of Clinical Hepatobiliary Diseases, 2019, 36(03):514-518. 

[8] Gatenby R A. A change of strategy in the war on cancer[J]. Nature, 2009, 459(7246):508-509

[9] Zhou B. Ancient literature study on traditional Chinese medicine syndromes related to liver cancer [J]. Chinese Journal of Traditional Chinese Medicine, 2011, 29(12):2714-2716. 

[10] Huang Qian, Li Jingtao, Chang Zhanjie, et al. Li Jingtao's experience in the diagnosis and treatment of precancerous liver cancer [J]. Journal of Integrated Traditional Chinese and Western Medicine Hepatology, 2019, 30(03):246-248. 

[11] Liang Guoying, Li Ming, Wang Haiqiang. Study on mechanism of traditional Chinese medicine intervention in liver cancer prelesions [J]. Chinese Journal of Traditional Chinese Medicine, 2011, 29(3):555-556. 

[12] Chao Yuanfang. On the source and symptoms of various diseases [M]. Notes by Song Baiyang. Beijing: china medical science press, 2011:110. 

[13] Yan Jianguo, Yao Shukun. Differentiation and treatment of primary liver cancer by traditional Chinese medicine [J]. Journal of Integrated Traditional Chinese and Western Medicine Hepatology, 2010, 20(03):189-191. 

[14] Liu Shuang, Cao Zhengmin, Lv Wenliang, et al. Lv Wenliang's experience in the treatment of liver cancer [J]. Jilin Chinese Medicine, 2021, 41(03):313-316

[15] Chen Chen, Liu Li, Chang Zhanjie, et al. Study on the correlation between traditional Chinese medicine syndrome types and clinical indexes of liver cancer precancerous lesions [J]. Hepatology Journal of Integrated Traditional Chinese and Western Medicine, 2019, 31(03):205-208. 

[16] Wei Ailing, Guan Zhijie, Qiu Hua. A preliminary study on toxoturbidity and the pathogenesis of primary liver cancer [J]. Liaoning Journal of Traditional Chinese Medicine, 2009, 36(7):1088-1089. 

[17] Meng Bobo, Rui Ran, Dong Xia, et al. Research progress on prevention and treatment of malignant transformation of liver cancer precancerous lesions by traditional Chinese medicine [J]. Journal of Hebei Traditional Chinese Medicine, 2018, 40(11):1752-1756. 

[18] Sun Dongxue, Yang Zhu, Long Fengxi, et al. Study on traditional Chinese Medicine Treatment of liver cancer precancerous lesions based on alcoholic injury theory [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2019, 22(6):56-60. 

[19] Wang Ke, Li Jingtao, Yan Shuguang, et al. Effect of intestinal microecology on malignant transformation of hepatocirrhose-liver precancer [J]. Journal of Gastroenterology and Hepatology, 2018, 27(1):111-114. 

[20] Han Q. Effect of intestinal microecology on malignant transformation of liver cirrhosis and liver cancer precancerous lesions [J]. Continuous Electronic Journal of World Latest Medical Information Abstracts, 2019, 19(83):50-50

[21] Zhang Tingting, Liu Mingkun, Ni Yao. Professor Lv Wenliang's experience in the treatment of chronic liver disease with antipathy [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2018, 20(12):132-134

[22] Qiang Rui, Lv Wenliang. Modified Yupingfeng powder for treating liver cancer related fatigue [J]. Global Chinese Medicine, 2021, 14(10):1878-1880

[23] Du Lin, Chen Deyao, Gu Chengjuan, et al. Tong Xiaolin's experience in treating liver cancer with Epimedium, Zedoary and Notoginseng [J]. Jilin Journal of Traditional Chinese Medicine, 2021, 41(1):16-18

[24] Zhao ZhiMei, Zhang LiJie. Research progress on anti-inflammatory and antitumor effects of main components of Zedoary [J]. Drug Evaluation Research, 2017, 40(1):119-124

[25] Chen Zeshan, Deng Xin, Chen Rudi, et al. Effect and potential mechanism of Astragalus on hepatocellular carcinoma [J]. Chinese Journal of Traditional Chinese Medicine, 2022, 41(11): 157-160. 

[26] Rui Ran, Dong Xia, Meng Bobo, et al. Research progress on signaling pathways related to the occurrence and development of liver cancer prelesions induced by Chinese traditional medicine active ingredients [J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 46(5):1114-1116

[27] Hong Y, Sheng L, Li H, et al. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice[J]. Gut Microbes, 2021, 13(1):1-20

[28] Qu Mengyang, Pan Yanfang, Xie Min, et al. Research progress of intestinal microecology in the occurrence and development of liver cancer prelesions [J]. Journal of Integrated Chinese and Western Medicine Hepatology, 2022, 32(5):472-474. 

[29] Qiang Rui, Wang Yanhong, Wu Qingjuan, et al. Study on the treatment of primary liver cancer with hawthorn based on the theory of "seeking together" [J]. Journal of Yunnan College of Traditional Chinese Medicine, 2020, 43(6):26-31. 

[30] Lu Aiyi, Xue Boyu. Guan Youbo's experience in treating chronic liver disease [J]. Henan Chinese Medicine, 2013, 33(04):521-522. 

[31] Zhu Guiying, Hu Fenglin, Zhou Wenting, et al. Xie Jianguo's experience in treating cancer with common drugs [J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 47(2):59-62. 

[32] Li Suting, Chen Long, Wang Ran, et al. Experimental study on the protective effect of total flavonoids from Hawthorn leaves on acute alcoholic liver injury in mice [J]. Shi Zhen Chinese Medicine, 2012, 23(11):2903-2904

[33] Zhao Jiling, Yang Wenhui. Protective effect of total flavonoids of Hawthorn on liver fibrosis induced by carbon tetrachloride in rats and its mechanism [J]. Henan Medical Research, 2013, 22(5):651-654

[34] Sun Siming, Xu Hongwei, Guo Kaiyuan, et al. Effect of Hawthorn proanthocyanidins on proliferation and apoptosis of human hepatocellular carcinoma SMMC-7721 cells [J]. Food Science, 2019, 40(5):189-196

[35] Wang Yanjie, Wang Yang, Li Mingzhu, et al. Research status of the molecular mechanism of the anti-liver cancer of Hedyotis alba [J]. Chinese Journal of Medicine, 2014, 42(3):161-163. 

[36] Liu Xiaohui, Zhan Sheng, Lin Xiukun, et al. Effects of Hedyotis alba, Schistoderma alba and their drug compatibility on glucose uptake capacity and lactate level of human pancreatic cancer Panc28 cells and human hepatoma Bel7402 cells [J]. Journal of Traditional Chinese Medicine, 2019, 61(10):890-895

[37] Che Yafeng. Observation on the clinical effect of salvia miltiorrhiza in the treatment of chronic liver disease [J]. World Latest Medical Information Digest Continuous Electronic Journal, 2016, 16(99):19-20. 

[38] Li Jie, Xu Chunjun. Guan Youbo's analysis of common antidrug application in treatment of liver disease [J]. Beijing Chinese Medicine, 2016, 35(4):318-319. 

[39] Qiu Peirong, Deng Xin, Zhuang Shuolin, et al. Research progress of the potential mechanism of salvia miltiorrhiza against liver cancer [J]. Chinese Journal of Traditional Chinese Medicine, 2023, 41(01):103-106. 

[40] Bai Qingyun, Tao Simin, Tian Jinhong, et al. Research progress of the effect and mechanism of scutellaria baicalensis on liver disease [J]. Chinese Journal of Traditional Chinese Medicine, 2019, 45(12):2808-2816. 

[41] Cao Fang, Yang Fusheng, Qian Tingting, et al. Analysis on the treatment of tumor with Biejia decoction pills with three Yang homology [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 36(5):2796-2798. 

[42] Peng Tao. The clinical application of Biejia decoction pill in the treatment of liver cancer [J]. Hepatology Journal of Integrated Traditional Chinese and Western Medicine, 2019, 30(6):481-483. 

[43] Huang Hongna, Huang Jingjing, Mao Dewen, et al. Effect of Biejia Decoction Pill on angiogenesis and microenvironment of precancerous liver cancer in rats [J]. Shi Zhen Chinese Medicine, 2016, 27(11):2570-2572

[44] Chen Weicong, Wen Bin, He Songqi, et al. Effect of Biejia Decoction Pill on IL-6/STAT3 signaling pathway in liver tissue of rats with diethylnitrosamine-induced precancerous lesion [J]. Journal of Traditional Chinese Medicine, 2021, 62(19):1720-1727

[45] Zhang Wenfu, Huang Jingjing, Lv Jianlin. Research progress of Jingfangbiejia decoction pill in the treatment of liver disease [J]. Journal of Guangxi University of Traditional Chinese Medicine, 2019, 22(1):57-60

[46] Gao Chanchan, Li Jingtao, Liu Yonggang, et al. Professor Chang Zhanjie's experience in the diagnosis and treatment of liver cancer with the idea of "Liver disease treating spleen" [J]. Journal of Integrated Chinese and Western Medicine Hepatology, 2019, 31(3):278-280

[47] Liu Yazhu, WEI Hailiang, Yan Shuguang, et al. Effect of Yipi Yanggan Prescription on expression of PCNA and GGT protein in rat liver cancer precancerous tissues [J]. Shaanxi Traditional Chinese Medicine, 2017, 38(02):264-266

[48] Li Jingtao, Wei Hailiang, Chang Zhanjie, et al. Effect of Yipi Yanggan Prescription on serum IL-6 and TNF-α in rats with precancerous liver disease [J]. Journal of Modern Integrated Chinese and Western Medicine, 2018, 27(03):236-239

[49] Guan Qian, Liu Wei, Chen Jiamei, et al. Clinical and basic research progress of Fuzheng Huayu prescription in treatment of chronic liver disease [J]. Journal of Clinical Hepatobiliary Diseases, 2019, 37(6):1449-1453. 

[50] Fan Haina, Huang Kai, Liu Chenghai, et al. Effect and mechanism of Fuzheng Huayu prescription on hepatocellular carcinoma in mice with liver fibrosis [J]. Chinese Journal of Integrated Traditional and Western Medicine Digestion, 2019, 31(02):110-117. 

[51] Tian Sinan, Yue Xinyu, Yi Yi, et al. Research progress of acupuncture and moxibustion in prevention and treatment of liver cancer [J]. Journal of Integrated Traditional Chinese and Western Medicine Hepatology, 2017, 27(01):60-61. 

[52] Liu Zeyin, Zhang Haibo, Luo Ying, et al. Yu Yun Observation of therapeutic effect of pulse-cutting acupuncture on advanced liver cancer [J]. Journal of Guangzhou University of Chinese Medicine, 2018, 35(1):66-69. 

[53] Zhang Le, Xu Teng, Liao Jun, et al. Effect of moxibustion on expression of PCNA, CyclinD1 and CDK4 in liver cancer transplanted nude mice [J]. Shi Zhen Chinese Medicine, 2014, 25(4):1001-1003

[54] Jia Wenrui, Dong Feng, Xie Xiliang, et al. Effect of direct moxibustion "Gan Shu" on apoptosis inhibitory factors in rats with primary liver cancer precancerous lesions [J]. Acupuncture Research, 2014, 39(3):211-215. 

[55] Ding Jingjing, Qian Guoqiang, Zhang Xiaozhao, et al. Research progress of traditional Chinese medicine in prevention and treatment of liver cancer prelesions [J]. Chinese Journal of Gerontology, 2018, 38(18):4586-4588.